David E. I. Pyott

Companies

• Tarsus Pharmaceuticals, Inc.Board member Feb 20, 2026 to now¹
• Pliant (United States)Board member Jan 13, 2021 to now²
• Alnylam PharmaceuticalsBoard member Dec 22, 2015 to now³
• BioMarin PharmaceuticalBoard member Jan 6, 2016 to May 23, 2024⁴
• Avery DennisonBoard member Jul 2, 2003 to Apr 24, 2020⁵
• Allergan plcChief executive officer Feb 8, 2006 to Mar 19, 2015⁶
• Allergan plcChair Feb 8, 2006 to Mar 19, 2015⁶
• Edwards LifesciencesBoard member May 15, 2006 to May 13, 2014⁷
• Allergan plcPresident Feb 8, 2006 to Feb 22, 2013⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Alnylam Pharmaceuticals ALNY29,482 shares⁸$6.9M at $235.58Jun 3, 2026
• Avery Dennison AVY18,684 shares⁹$3.3M at $178.32Apr 23, 2020
• BioMarin Pharmaceutical BMRN49,750 shares¹⁰$2.7M at $54.75May 21, 2024
• TPTarsus Pharmaceuticals, Inc. TARS10,958 shares¹¹$763.1K at $69.64Sep 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 15, 2026Exercised options 201 shares of Tarsus Pharmaceuticals, Inc.¹¹
• Jun 1, 2026Sold 17 shares at $302.65 of Alnylam Pharmaceuticals⁸
• Jun 1, 2026Sold 495 shares at $300.72 of Alnylam Pharmaceuticals⁸
• Jun 1, 2026Sold 1,222 shares at $299.87 of Alnylam Pharmaceuticals⁸
• Jun 1, 2026Sold 1,175 shares at $298.91 of Alnylam Pharmaceuticals⁸
• Jun 1, 2026Sold 921 shares at $297.71 of Alnylam Pharmaceuticals⁸
• Jun 1, 2026Exercised options 3,830 shares of Alnylam Pharmaceuticals⁸
• May 20, 2026Granted 671 shares of Alnylam Pharmaceuticals¹²
• Apr 24, 2026Exercised options 1,383 shares of Tarsus Pharmaceuticals, Inc.¹³
• May 8, 2025Granted 775 shares of Alnylam Pharmaceuticals¹⁴
• Mar 24, 2025Sold 7,440 shares at $299.00 of Alnylam Pharmaceuticals¹⁵
• Mar 24, 2025Exercised options 7,440 shares at $88.95 of Alnylam Pharmaceuticals¹⁵
• Jun 24, 2024Sold 7,470 shares at $222.00 of Alnylam Pharmaceuticals¹⁶
• Jun 24, 2024Sold 7,420 shares at $221.00 of Alnylam Pharmaceuticals¹⁶
• Jun 24, 2024Sold 17,560 shares at $220.00 of Alnylam Pharmaceuticals¹⁶
• Jun 24, 2024Exercised options 7,470 shares at $71.99 of Alnylam Pharmaceuticals¹⁶
• Jun 24, 2024Exercised options 7,420 shares at $70.20 of Alnylam Pharmaceuticals¹⁶
• Jun 24, 2024Exercised options 17,560 shares at $88.95 of Alnylam Pharmaceuticals¹⁶
• May 21, 2024Granted 4,720 shares of BioMarin Pharmaceutical¹⁰
• May 23, 2023Granted 4,190 shares of BioMarin Pharmaceutical¹⁷
• Feb 23, 2023Exercised options 136 shares of Alnylam Pharmaceuticals¹⁸
• May 24, 2022Granted 4,980 shares of BioMarin Pharmaceutical¹⁹
• Apr 23, 2020Exercised options 1,414 shares at $107.56 of Avery Dennison⁹
• Feb 3, 2020Sold 5,027 shares at $132.72 of Avery Dennison²⁰
• Feb 3, 2020Exercised options 5,027 shares at $38.18 of Avery Dennison²⁰

Trade performance

Returns are price-only (no dividends), measured from the trade date.